Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant expression of miR-451a contributes to 1,2-dichloroethane-induced hepatic glycerol gluconeogenesis disorder by inhibiting glycerol kinase expression in NIH Swiss mice. | J Appl Toxicol | 2018 | 28960355 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Non-Synonymous Natural Variants of G Protein-Coupled Receptors. | Biomol Ther (Seoul) | 2018 | 28934823 | PubTator, text mining | PubMed |
| Impact of Perioperative Blood Transfusion on Survival Among Women With Breast Cancer: Potential Benefits of Blood-Saving Agent Desmopressin Use During Surgery. | Am J Ther | 2018 | 28806181 | PubTator, text mining | PubMed |
| Avian genomics lends insights into endocrine function in birds. | Gen Comp Endocrinol | 2018 | 28596079 | PubTator, text mining | PubMed |
| Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children? | Pediatr Nephrol | 2018 | 28455745 | PubTator, text mining | PubMed |
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. | Nephrol Dial Transplant | 2018 | 28379536 | PubTator, text mining | PubMed |
| GPCR desensitization: Acute and prolonged phases. | Cell Signal | 2018 | 28137506 | PubTator, text mining | PubMed |
| Results and prospects of development of new polyphenolic drugs for cancer patients. | Oncotarget | 2017 | 33400728 | PubTator, text mining | PubMed |
| Is It Ethical to Test Apparently "Healthy" Children for Autosomal Dominant Polycystic Kidney Disease and Risk Medicalizing Thousands? | Front Pediatr | 2017 | 29404310 | PubTator, text mining | PubMed |
| Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness. | Medicine (Baltimore) | 2017 | 29384972 | PubTator, text mining | PubMed |
| Many Genes-One Disease? Genetics of Nephronophthisis (NPHP) and NPHP-Associated Disorders. | Front Pediatr | 2017 | 29379777 | PubTator, text mining | PubMed |
| The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians. | Front Pediatr | 2017 | 29326913 | PubTator, text mining | PubMed |
| Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder? | Front Pediatr | 2017 | 29326910 | PubTator, text mining | PubMed |
| Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients. | Indian J Anaesth | 2017 | 29307906 | PubTator, text mining | PubMed |
| Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer. | Onco Targets Ther | 2017 | 29276392 | PubTator, text mining | PubMed |
| Are respiratory complications of Plasmodium vivax malaria an underestimated problem? | Malar J | 2017 | 29273053 | PubTator, text mining | PubMed |
| Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome. | J Endocr Soc | 2017 | 29264446 | PubTator, text mining | PubMed |
| Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system. | Nat Commun | 2017 | 29263378 | PubTator, text mining | PubMed |
| Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. | Oncotarget | 2017 | 29262666 | PubTator, text mining | PubMed |
| Deciphering the Relationship between Obesity and Various Diseases from a Network Perspective. | Genes (Basel) | 2017 | 29258237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=71